Back to Insulin research
insulin gip agonist 2026-04-03 PubMed

Retatrutide Shows Multiple Metabolic Benefits in Diet-Induced Obese MASH Mouse and Hamster Models.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


insulin retatrutide gip agonist glp 1 agonist glucagon agonist dose mentioned
Source: pubmed:41741376 · Ingested Apr 3, 2026